Key Advances in the Systemic Therapy for Soft tissue Sarcomas: Current Status and Future Directions
Soft tissue sarcomas (STS) represent a heterogeneous group of diverse neoplasms of mesenchymal origin. Once relapsed from standard therapy, STS patients have limited treatment options especially those that present with advanced or metastatic disease. In this review article, we highlight recent clini...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2013-10-01
|
| Series: | European Medical Journal Oncology |
| Subjects: | |
| Online Access: | http://emjreviews.com/wp-content/uploads/Key-Advances-in-the-Systemic-Therapy-for-Soft-tissue-Sarcomas-Current-Status-and-Future-Directions.pdf |